Condensed Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	3 Months Ended
Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Revenue	$ 49,603	$ 43,968
Cost of Goods and Services Sold	47,989	42,326
Gross margin	1,614	1,642
Operating expenses:
Distribution, selling, general and administrative expenses	1,197	1,114
Restructuring and employee severance	29	18
Amortization and other acquisition-related costs	71	79
Impairments and (gain)/loss on disposal of assets, net	153	(2)
Litigation (recoveries)/charges, net	27	18
Operating earnings	137	415
Other (income)/expense, net	2	(4)
Interest expense, net	25	40
Loss on early extinguishment of debt	0	10
Earnings before income taxes	110	369
Provision for/(benefit from) income taxes	(1)	97
Net earnings	111	272
Less: Net earnings attributable to noncontrolling interests	(1)	(1)
Net earnings attributable to Cardinal Health, Inc.	$ 110	$ 271
Earnings per common share attributable to Cardinal Health, Inc.:
Basic (in shares)	$ 0.41	$ 0.94
Diluted (in shares)	$ 0.40	$ 0.94
Weighted-average number of common shares outstanding:
Basic (in shares)	271	287
Diluted (in shares)	273	289
Cash dividends declared per common share	$ 0.4957	$ 0.4908

The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.

No definition available.